These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33956182)

  • 1. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure.
    Izumida T; Imamura T; Ueno Y; Tanaka S; Kataoka N; Nakamura M; Kinugawa K
    Heart Vessels; 2021 Nov; 36(11):1688-1693. PubMed ID: 33956182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implication of optimal heart rate in patients with systolic dysfunction following TAVR.
    Imamura T; Tanaka S; Ushijima R; Sobajima M; Fukuda N; Ueno H; Besser S; Kinugawa K
    J Card Surg; 2021 Apr; 36(4):1328-1333. PubMed ID: 33538004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction.
    Martens P; Beliën H; Dupont M; Vandervoort P; Mullens W
    Cardiovasc Ther; 2018 Aug; 36(4):e12435. PubMed ID: 29771478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Doppler echocardiography-guided ivabradine therapy.
    Izumida T; Imamura T; Kinugawa K
    Heart Vessels; 2023 Jan; 38(1):49-55. PubMed ID: 35789418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
    Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
    Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
    Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
    Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Auger D; van Bommel RJ; Bertini M; Delgado V; Ng AC; Ewe SH; Shanks M; Marsan NA; Mooyaart EA; Witkowski T; Poldermans D; Schalij MJ; Bax JJ
    Am Heart J; 2010 Oct; 160(4):737-43. PubMed ID: 20934569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to consider target heart rate in patients with systolic heart failure.
    Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K
    ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure.
    Sabbah HN; Gupta RC; Kohli S; Wang M; Rastogi S; Zhang K; Zimmermann K; Diedrichs N; Albrecht-Küpper BE
    Circ Heart Fail; 2013 May; 6(3):563-71. PubMed ID: 23564604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.